Bovine viral diarrhea virus (BVDV) is an economically important pathogen of cattle. A successful control program requires early detection and removal of persistently infected (PI) animals. The objective of the current study was to develop, validate, and apply a cost-effective testing scheme for the detection of BVDV PI animals in exposed herds. Pooled samples were screened by using a real-time reverse transcription polymerase chain reaction (real-time RT-PCR), and individual positives were identified with an antigen capture enzyme-linked immunosorbent assay (ACE). The detection limits of the optimized realtime RT-PCR were 10 and 100 RNA copies per reaction for BVDV-1 and BVDV-2, respectively. The semiquantitative results of real-time RT-PCR and ACE or real-time RT-PCR and immunohistochemistry were moderately correlated. The threshold cycle of real-time RT-PCR performed on pooled samples was significantly correlated with the pool size (R 2 5 0.993). The least-cost pool sizes were 50 at a prevalence of 0.25-0.5% and 25 at a prevalence of 0.75-2.0%. By using the combined real-time RT-PCR and ACE procedure, 111 of 27,932 samples (0.4%) tested positive for BVDV. At this prevalence, cost reduction associated with the application of real-time RT-PCR and ACE ranged from 61% to 94%, compared with testing individual samples by ACE, immunohistochemistry, or real-time RT-PCR. Real-time RT-PCR screening also indicated that 92.94% of PI animals were infected with BVDV-1, 3.53% with BVDV-2, and 3.53% with both BVDV-1 and BVDV-2. Analysis of the 59-untranslated region of 22 isolates revealed the predominance of BVDV-1b followed by BVDV-2a.
Introduction
Bovine viral diarrhea virus (BVDV) is an economically important pathogen of cattle worldwide, 10 and, along with Classical swine fever disease virus (CSFV) and Border disease virus, is a member of the Pestivirus genus in the family Flaviviridae. 14 The virus has a broad tissue tropism and can infect many cell types of the bovine host. 14 The 2 biotypes of BVDV, cytopathic and noncytopathic, are distinguished according to their effects on cultured cells. 18 Bovine viral diarrhea virus isolates can be further classified by genotypes, BVDV-1 and BVDV-2, and subgenotypes on the basis of sequence variations in the 59untranslated region (UTR) of the viral genome. 23 The BVDV isolates of either genotypes can have a biotype of cytopathic or noncytopathic, and the relationship between genotype and pathogenesis remains to be clearly defined. 6 Bovine viral diarrhea virus infection is associated with a diverse array of diseases, including gastrointestinal disorder, respiratory distress, fetal malformation, stillbirth, abortions, and mucosal disease. 2 Transplacental infections of fetuses between 42 and 125 days of gestation can result in immune tolerance, and the surviving fetuses become persistently infected. Persistently infected (PI) animals continually shed a large amount of virus in their body secretions and excretions, thereby serving as a reservoir for BVDV. 2, 15, 17 Cattle exposed to PI animals have a higher incidence of respiratory diseases and associated risk for treatment. 15 Early detection and subsequent removal of PI animals is essential to a successful disease control program, which, however, is often hindered by the high cost associated with laboratory testing.
Many test methods have been developed for the detection of BVDV, including virus isolation (VI), immunohistochemistry (IHC), reverse transcription polymerase chain reaction (RT-PCR), and antigen capture enzyme-linked immunosorbent assay (ACE). 1, 4, 5, 24, 26, 27 Each test has its own strengths and weaknesses in terms of sensitivity, cost, and turnaround time. Although VI is still perceived as the criterion standard, it is laborious, time consuming, and unsuitable for whole-herd testing. 22, 24 ACE is suitable for screening large numbers of samples; however, the cost for testing individual animals is relatively high. 5, 26 Immunohistochemistry detects viral antigens by staining formalin-fixed, paraffinembedded skin biopsy specimens, which is time intensive and can only be applied on tissue samples. 4 Real-time RT-PCR has been widely accepted in recent years because of its rapid turnaround time and high sensitivity that, in principle, enables the testing of pooled samples. 3, 8, 16 The objective of the current study was to develop, validate, and apply a cost-effective, reliable, and rapid testing protocol for the detection of BVDV PI animals in exposed herds. To achieve this goal, realtime RT-PCR was optimized to detect extremely low numbers of BVDV in clinical specimens. Pooled samples were screened by real-time RT-PCR, and individual positive samples were then identified by ACE. The validity of the combined real-time RT-PCR and ACE testing scheme was assessed by performing intertest and intersample type comparisons. The least-cost pool sizes were determined based on the predicted prevalence.
Materials and methods

Virus and cell culture
Bovine viral diarrhea virus Singer (type 1) and BVDV 125c (type 2) were obtained from the National Veterinary Services Laboratories (NVSL). a The Madin-Darby bovine kidney cell line free of BVDV was maintained in minimum essential medium supplemented with 5% horse serum b in 75-cm tissue culture flasks. After inoculation of Madin-Darby bovine kidney cell line with BVDV, the cultures were incubated at 37uC and observed daily for cytopathic effect. The inoculated cultures that showed 70-80% cytopathic effect were subjected to a freeze-thaw cycle and low-speed centrifugation for 10 min at 1,000 3 g. The culture supernatants were collected, divided into aliquots, and then stored at 280uC before use. The virus stocks were titrated in 96-well microtiter plates, and the titers (log 50% tissue culture infective dose [TCID 50 ]) were calculated as previously described. 21 
Sample collection, preparation, and pooling
Serum samples from 899 animals and skin biopsy (ear notch) samples from 27,033 animals submitted to the Mississippi Veterinary Research and Diagnostic Laboratory (Pearl, Mississippi) between 2006 and 2008 for the diagnosis of bovine viral diarrhea were used in the present study. Approximately 2 ml of nonhemolytic serum was taken from each of the original samples for further testing. The ear notches, approximately 1.25 cm in diameter (0.19 6 0.02 g), were placed in individual sterile tubes that contained 2 ml of 0.1 M phosphate buffered saline solution (PBS; pH 7.4), supplemented with 0.02% sodium azide as a preservative. After a brief vortexing (10 sec) and 10-min incubation at room temperature, the supernatants of the ear notch-PBS suspensions were collected for further testing. The aliquots of serum and ear-notch extracts were refrigerated at 4uC before being tested by real-time RT-PCR and ACE within 1 week. All ACE-positive as well as 50 ACE-negative ear notches were cut into 2 halves. Onehalf was fixed in 10% neutral formalin for IHC, whereas the other half, in PBS, was stored at 280uC for later use. To screen a herd for the presence of BVDV PI animals, the samples were pooled by mixing equal volumes (200 ml) of sera or ear notch-PBS extracts from 25 to 50 individual animals of the same herd. The pool sizes (25-50) were chosen based on 2 factors, the number of samples to be tested and the lowest possible diagnostic cost per animal. The prevalence (0.5%) data for the year 2005 generated by testing individual samples were used for cost estimation.
RNA extraction
Two methods were used to extract RNA from different samples. For serum samples, RNA was extracted from either 200 ml of nonhemolytic individual or 200 ml of pooled sample by using a commercially available RNA purification system, designated as ''A.'' c With ear-notch extracts, cell-cultured BVDV, viral stocks, and bacterial stocks, RNA was isolated from 500 ml of supernatant by using a commercial RNA purification kit, designated as ''B.'' d RNA extraction was carried out by following the manufacturers' instructions with minor modifications (2 additional washes of RNA pellets or columns). RNA was either resuspended in A or eluted with B in 50 ml of distilled DNase-and RNase-free H 2 O. The RNA preparations were stored at 280uC before real-time RT-PCR analysis.
Primers and probes
Two sets of primers and probes that target BVDV 59-UTR were derived from previous publications. 3, 13 Two additional sets of primers and probes that target the same region were designed by using the Primer Express e software. All primers and probes were commercially synthesized. f Two common primers for BVDV-1 and BVDV-2, and 2 distinct probes capable of differentiating the 2 genotypes were included in the real-time RT-PCR assay. The 59 ends of the BVDV-1 and BVDV-2 probes were labeled with fluorescent reporter molecules, 6carboxyfluorescein (FAM) and cyanine 5 (Cy5), respectively, whereas the 39 ends were labeled with the Black Hole Quencher dye (BHQ-1). To clone the 59-UTR, primers BVDV-LYF 59-TAGCCATGCCCT TAGTAGGAC-39 and BVDV-LYR 59-CTCCATGTGCCATGTACAGCA-39 were used.
Real-time RT-PCR procedure
One-step real-time RT-PCR was performed by using commercial reagents according to the manufacturer's instructions. g The optimal annealing temperature for a given combination of primers and probes was determined by increasing the temperature from 55uC to 59uC in increments of 1uC. The optimal concentrations of primers and probes were determined by titration between 0.1 mmol and 1 mmol. The optimal MgCl concentration was determined by titration between 1.5 mM and 2.5 mM. The final volume of real-time RT-PCR was 25 ml, which contained 8 ml of sample RNA and 17 ml of reagent mixture with 2.5 mM MgCl 2 , 10 mM deoxyribonucleotide triphosphates, 0.2 mmol of forward primer, 0.2 mmol of reverse primer, 0.24 mmol of BVDV-1 probe, 0.96 mmol of BVDV-2 probe, 5 mmol of random hexamers, 10 U of RNase inhibitor, and 1 ml of enzymes. g The reactions were carried out on a programmable thermocycler h as follows: 48uC for 25 min; 95uC for 10 min; 50 cycles of 95uC for 25 sec, 56uC for 25 sec, 72uC for 30 sec; and final elongation at 72uC for 10 min. To avoid potential contaminations associated with BVDV-contaminated bovine serum, equine serum was used for cell culture and propagation of viruses. Procedures for sample processing, PCR reaction setup, PCR amplification, and cell culture were performed in separate laboratory sections.
Preparation of BVDV control RNA
The 59-UTRs of BVDV-1 and BVDV-2 were amplified by PCR and cloned in the TOPO (topoisomerase I) TA (Taq-amplified) cloning vector i downstream of the T7 promoter to yield plasmids pBVDV-I-59 and pBVDV-II-59, respectively. The 2 plasmids were linearized with restriction enzyme BamHI and purified by phenol-chloroform extraction and ethanol precipitation. The control RNA was transcribed from the T7 promoters by using a T7 RNA polymerase according to the manufacturer's instructions. j The transcribed RNA was purified by using a RNA purification kit d to remove nonincorporated nucleotides and then quantified by spectrophotometry.
Determination of real-time RT-PCR sensitivity and specificity
The analytical sensitivities were determined by performing real-time RT-PCR assays by using RNA prepared from the following: 1) 10-fold serial dilutions of BVDV-1 and BVDV-2 stocks, 2) pooled negative ear-notch samples (n 5 25) spiked with serial dilutions of viral stocks, 3) 10-fold serial dilutions of in vitro transcribed BVDV-1 and BVDV-2 59-UTR RNA, and 4) pooled negative ear samples (n 5 25) spiked with serial dilutions of in vitro transcribed RNA. The input amount of viruses and RNA ranged from 0.33 to 6.33 log TCID 50 or 1-8 log RNA copies per reaction. Standard curves were generated by plotting threshold cycle (Ct) values in the logarithmic linear phase of amplification against the log TCID 50 or log RNA copies. The detection limits of real-time RT-PCR were determined as the last dilution at which all replicate reactions gave positive results.
The specificity was evaluated by performing real-time RT-PCR by using RNA extracted from 10-fold serial dilutions ( To assess the effect of sample pooling on the sensitivity of real-time RT-PCR, positive (PCR and ACE) ear-notch extracts (n 5 8) were used to artificially contaminate negative ear-notch pools of different sizes. The pools were created by mixing equal volumes (100 ml) of ear-notch extracts from 1 positive sample and 11, 24, or 49 negative samples, which yielded a final pool size of 12, 25, or 50, respectively. Real-time RT-PCR assays were subsequently carried out by using RNA prepared from these pools.
Antigen capture ELISA and IHC ACE detection of BVDV in sera and ear notches was conducted by using a commercially available test kit per manufacturer's instructions. k Immunohistochemical detection of BVDV antigen was conducted as described previously. 4, 28 Briefly, the ear-notch samples were fixed in 10% neutral formalin for 2-3 weeks, embedded in paraffin, and sectioned at 5 mm. Tissue sections were treated with proteinase K, l followed by incubation with a primary monoclonal antibody against BVDV m and alkaline-phosphatase reagents n per manufacturers' instructions. The IHC staining was graded by 2 pathologists by using a 4-point scale system similar to a previously described study. 28 A consensus grade of the 2 pathologists was assigned to each sample. In brief, positive results were interpreted as 1 5 faint minimal staining, 2 5 mild staining, 3 5 moderate staining, and 4 5 marked intense staining. Negative staining was scored as 0.
Testing scheme and cost structural analysis
For cost-effectiveness, the samples were pooled and screened by real-time RT-PCR, and individual samples in positive pools were then tested by ACE. The cost for screening BVDV PI animals was predicted for herd prevalence that ranged from 0.25% to 2.0% as described previously. 20 The costs of the 3 tests, estimated based on the costs of reagents and labor as well as the actual fees of several diagnostic laboratories, were as follows: ACE, $4-$8 (average $6); IHC, $3-$7 (average $5); real-time RT-PCR, $25-$45 (average $35); and VI, $20-$40 (average $30). The cost was assumed to be the same for a given type of test performed on an individual sample or a pooled sample. The prevalence of BVDV-positive animals in a herd was assumed to be 0.25%, 0.3%, 0.5%, 0.75%, 1.00%, 1.25%, 1.50%, 1.75%, and 2.00%. The costs for individual real-time RT-PCR and ACE tests were assigned as c and d, respectively. The prevalence was represented by p. The total number of animals in a herd was designated as N, the pool size as k, and the number of pools as r, where r 5 N/k, with assuming r is an integer. A positive pool was expected to contain at least 1 positive sample. The probability that a pool would test positive was the binomial probability, r 5 1 2 (1 2 p) k . Thus, the cost for pools of r was cr + dr[1 2 (1 2 p) k ]*k, and the cost for testing each animal was c/k + d [1 2 (1 2 p) k ]. The costs for testing individual animals for different pool sizes and prevalence rates were determined. The cost reductions associated with the application of the combined real-time RT-PCR and ACE testing scheme, compared with testing individual animals by ACE, IHC, and real-time RT-PCR were assessed based on the local prevalence and sample pool size used.
Genetic analysis of the field isolates
The 59-UTR of BVDV isolates were PCR amplified and cloned into a TA cloning vector, i and sequenced by a commercial sequencing facility. o The sequences of 22 local BVDV isolates, 23 reference strains (12 BVDV-1 and 11 BVDV-2), 4 reference Border disease virus strains, and 4 reference CSFV strains were compared. The 59-UTR sequences were aligned by using ClustalX version 2.0. 12 Maximum parsimony and neighbor-joining analyses were performed by using PAUP* 4.0 Beta as described previously. 30 Maximum likelihood tree estimation was evaluated by using GARLI version 0.951. 30 Tree topologies were confirmed between each of these 3 methods. Bootstrapping support for tree topologies was performed by using the neighbor-joining method implemented in PAUP* 4.0 Beta with 1,000 replicates.
Statistical analysis
The correlations between real-time RT-PCR Ct values and the input numbers of BVDV (log TCID 50 ) and between real-time RT-PCR Ct values and the pool sizes (ln dilution factors) was determined by linear regression analysis by using Excel 2000 software. p The correlations between different BVDV diagnostic tests, including real-time RT-PCR, ACE, and IHC, were determined by using the CORR procedure of SAS 9.1 software. q The Pearson correlation coefficient (r) was used as a measure of the strength of correlation, where +1 indicated a perfect linear correlation and 21 suggested a perfect inverse (negative) correlation. The criteria for interpreting the strength of correlations were 0.00-0.39, no correlation to weak correlation; 0.40-0.70, moderate correlation; and 0.7-1.0, strong correlation. A P value less than 0.05 indicated statistical significance.
Results
Sensitivity and specificity of real-time RT-PCR
Of the multiple primers and probes tested, a previously published set of primers and probes (BVDV-F2/BVDV-PESTR, BVDV-P-1, and BVDV-P-2) 13 demonstrated the highest sensitivity and lowest background noise (data not shown). These primers and probes were used throughout the current study to amplify the 59-UTR of BVDV-1 and BVDV-2. Linear correlations (R . 0.99) were found between the Ct value and the log TCID 50 or log RNA copies. The detection limits of the assay defined based on virus concentrations were 1.33 log TCID 50 per reaction for BVDV-1 and 2 log TCID 50 per reaction for BVDV-2. The detection limits on the input RNA copy numbers were 1 log copies per reaction for BVDV-1 and 2 log copies per reaction for BVDV-2 ( Fig. 1A) . When in vitro transcribed RNA mixed with negative ear-notch samples, the detection limits were 2 log copies per reaction for BVDV-1 and 3 log copies per reaction for BVDV-2 (Fig. 1B) . When the real-time RT-PCR assays were applied on 3 commonly isolated bovine viral pathogens and 6 bacterial strains, no fluorescent signals were detected, which suggested a satisfactory specificity. 
Correlation between testing methods
To validate the testing system, the correlations between the semiquantitative results of 3 methods were determined. Thirty-four archived ACE-positive ear notches (from positive pools) with sample-topositive (S/P) ratios that ranged from 0.4 to 1.4 were subjected to real-time RT-PCR analyses. The realtime RT-PCR Ct values were initially between 34 and 45 for pools that contained those individual positive samples. The pool sizes were between 25 and 50. After 1-year storage at 280uC and several cycles of freezethaw, 4 individual samples tested negative by realtime RT-PCR. For calculation convenience, a Ct value of 50 was assigned to these 4 samples. The Ct values for the 34 archived individual samples ranged from 29 to 50. For IHC confirmation, ear notches were fixed in 10% formalin within a week of their arrival to the diagnostic laboratory and then were processed for microscopic evaluations. Results of the present study indicated that the BVDV antigen was mainly present in the epithelial cells located at the epidermis and follicles. No differences in staining pattern and intensity were observed between infections with genotype 1 and 2 viruses or between infections with a single genotype and both genotypes. Consensus scores (1-4) obtained by 2 pathologists were assigned to the positive samples. Pearson correlation coefficients (r) and the probability values (P) showed that the correlations between the semiquantitative results of real-time RT-PCR and ACE or IHC were moderate and significant (r . 0.4, P , 0.05), whereas the correlation between ACE and IHC was weak (r 5 0.338, P 5 0.051; Table 1 ). The inverse correlation between Ct values and ACE S/P ratios or IHC grades was in accordance with the fact that Ct value is inversely related with the amount of input virus RNA.
Effect of sample pooling on real-time RT-PCR detection of BVDV
Eight PCR-positive ear notches with real-time RT-PCR Ct values that ranged from 30.54 to 34.10 were diluted with equal volumes of varying numbers of negative ear-notch samples to create pools of different sizes. Threshold cycle values for individual positive samples and the corresponding pools at sizes of 12, 25, and 50 are summarized in Table 2 . The changes in Ct versus the changes in sample pool size are presented in Figure 2A . Overall, a linear correlation (R 2 5 0.993) was found between the changes in Ct and Ln pool sizes (Fig. 2B) . At pool sizes of 12 and 25, the average (SD) increases in Ct were 5.02 6 0.94 and 6.49 6 1.53 cycles, respectively. At a pool size of 50, sharp increases in Ct values as well as intertest variations for 3 of the 8 samples (nos. 2, 5, and 8) were detected (Table 2, Fig. 2A ).
Prevalence of BVDV
From 2006 to 2008, a total of 27,932 animals were tested for BVDV persistent infection (Table 3) . A total of 22,732 samples (ear notch or sera from different animals) were subjected to real-time RT- 
RT-PCR (Ct value) ACE (S/P ratio) IHC staining grade
Real-time RT-PCR (Ct value) r 5 1.000 r 5 20.432 r 5 20.421 P 5 0.000 P 5 0.004 P 5 0.013 ACE (S/P ratio) r 5 20.432 r 5 1.000 r 5 0.338 P 5 0.004 P 5 0.000 P 5 0.051 * RT-PCR 5 reverse transcription polymerase chain reaction; Ct 5 threshold cycle; ACE 5 antigen capture enzyme-linked immunosorbent assay; S/P ratio 5 sample-to-positive ratio; IHC 5 immunohistochemistry. Pearson correlation coefficients (r) and the P value are indicators of the strength and significance of the correlation between 2 tests. A negative number indicates an inverse correlation between 2 tests. Results from 34 individual samples were subjected to analysis. PCR screening of pooled samples, followed by ACE testing of individual samples in positive pools. Approximately 5,300 ear-notch samples were tested directly by ACE. Immunohistochemistry was used to confirm results when it was necessary. Eighty-five of more than 1,000 pools at sizes that ranged from 25 to 50 tested positive by real-time RT-PCR, and 26 individual ear notches tested positive by direct ACE. The majority of positive pools contained 1 positive sample that was subsequently identified by ACE. Of the 85 positive pools, 3 pools (3.53%) contained 2 positive samples and 1 pool (1.18%) contained 3 positive samples. The average prevalence of BVDV in Mississippi for a 3-year period was 0.40%, with annual fluctuations of 0.24-0.72%, which was similar to previously reported prevalence of 0.3-0.5% in the central south United States. 7
Cost-effectiveness
The cost-effectiveness of the combined real-time RT-PCR and ACE testing scheme was evaluated for different pool sizes and prevalence rates ( Fig. 3) . At all pool sizes, the cost per animal associated with realtime RT-PCR/ACE increased as the prevalence increased. The least-cost pool size at prevalence of 0.25-0.50% was 50 and at a prevalence of 0.75-2.0% was 25. The second-best pool sizes for different prevalence were as follows: 100, 0.25%; 25, 0.30-0.50%; and 50, 0.75-2.0%. For instance, the cost per animal at a prevalence of 0.5% with sample pool sizes of 25 and 50 were predicted to be $2.11 and $2.03, respectively. For an average local prevalence of 0.40%, the predicted cost per animal for pools of 25 was $1.97 and for pools of 50 was $1.78. However, the true prevalence for a given farm or herd was unknown, and the cost per animal might have deviated slightly from the predicted dollar amount. At an average prevalence of 0.4%, application of the real-time RT-PCR and ACE screening protocol could reduce the cost per animal at a pool size of 25 by 67%, 61%, 94%, and 93%, compared with testing individual animals by ACE, IHC, real-time RT-PCR, and VI, respectively (Table 4 ).
Genetic analysis of BVDV field isolates
Genotyping by real-time RT-PCR showed that 92.94% of PI animals were infected with BVDV-1, 3.53% with BVDV-2, and 3.53% with both genotypes (1 and 2). Analysis of the 59-UTR of 22 field isolates suggested that all 18 BVDV-1 isolates belonged to the BVDV-1b subgenotype, whereas the 4 BVDV-2 isolates fell into the BVDV-2a subgenotype (Fig. 4) . Genetic variations among the isolates of each subgenotype were apparent. Within the BVDV-1b subgenotype, MS7 and MS14 were clustered with the KE strain; MS2 and MS9 were apart from other known strains; MS19 was closely related to the Osloss strain; MS5, MS1, and MS3 were related to the ILLNC strains; and MS6, MS10, MS8, and MS15, along with CP 7 and PAT, constituted another cluster. The BVDV-2b field isolates formed 2 distinct clusters with MS13 and MS20 more closely related to BVDV-II-AU501, and MS4 and MS12 to BVDV-II-890.
Discussion
Progress has been made in developing PCR-based assays for detection of BVDV in various clinical 3, 8, 11, 13, 16, 27, 31, 32 To validate real-time RT-PCR assay in the authors' laboratory, multiple primers and probes that target the 59-UTR of BVDV were compared, and a previously published combination demonstrated the highest sensitivity and consistency. 13 By following extensive optimization, the real-time RT-PCR assay was able to detect low numbers of viruses in viral stocks or in virus-spiked ear-notch samples. However, the analytical sensitivity determined based on TCID 50 titer could be affected by the viability of the stock virus. To overcome this inherent limitation, real-time RT-PCR standard curves were constructed by using serial dilutions of in vitro transcribed 59-UTR RNA, which again demonstrated high analytical sensitivities for both BVDV-1 and BVDV-2. In the present study, cell-free specimens were tested by real-time RT-PCR, which limited the use of housekeeping genes as an internal positive control. An external control, such as an unrelated RNA virus, could have been used to spike clinical samples before RNA extraction and RT-PCR as described previously. 32 Because of concerns about potential cross-contaminations, this technique was not adopted. The performance of the real-time RT-PCR was monitored via spiking negative specimens with known quantities of viruses or in vitro transcribed RNA.
Intra-and interlaboratory studies have shown that real-time RT-PCR, IHC, and ACE are all suitable for the detection of BVDV PI animals. 4, 5 Good correlations have been found between the qualitative results of ACE and IHC or IHC and real-time RT-PCR methods. 4, 9, 25 In the current study, the qualitative results of these tests were in 100% agreement for all positive samples, which was in accordance with previous reports. 4, 5 Further analysis of the quantitative results revealed a moderate, but significant, correlation between Ct value and S/P ratio or Ct value and IHC grade, indicating the usefulness of Ct in estimating BVDV load in specimens. No significant correlation occurred between the ACE S/P ratio and IHC grade, which might result from the limited capability of ACE to quantify viruses or the subjective grading system of IHC. The present study did not focus on the impact of ear-notch size on the quantitative results of real-time RT-PCR or ACE. A previous study showed that the amount of virus detected in ear-notch extract was not significantly affected by sample size over a wide weight range (0.75 g and 0.05 g; Ridpath It has been suggested that RT-PCR can detect individual positive serum or ear-notch samples in pools of 100 or more. 11, 31 The current study determined the validity of real-time RT-PCR for screening ear-notch pools by using multiple individual positives to spike negative pools of various sizes. One interesting observation from the current study was that the real-time RT-PCR Ct values for most PI animals fell in the range of 30-34 (approximately 4.7-3.6 log RNA copies). Theoretically, mixing a weak-positive Figure 3 . Cost structural analysis for the combined reverse transcription polymerase chain reaction and antigen capture enzyme-linked immunosorbent assay testing scheme. Cost per animal was calculated for different sample pool sizes at various presumed prevalence. The predicted least cost pool sizes are 25 samples per pool at prevalence from 0.75% to 2.0% and 50 samples per pool at prevalence from 0.25% to 0.50%. ear notch of Ct 34 with 99 negative samples (pool size of 100) would increase the Ct to 41.22, a value considered positive. However, the high Ct values and wide intertest variations for 3 of the 8 pools at a size of 50 indicated a risk of false-negative results associated with large pool sizes ($50).
The effect of sample pooling on the cost, sensitivity, and specificity of BVDV testing has been predicted by using mathematical models. 19, 20 Cost analysis for the combined real-time RT-PCR and ACE testing scheme indicated that 50, followed by 25, was the most costeffective pool size at prevalence from 0.25% to 0.50%. A comparison of the Ct values for individual positives in pools of various sizes suggested that pooling 25 samples had the desired minimal impact on real-time RT-PCR results. In addition, a pool size of 25 was conducive to ease of laboratory bench operation and data management. At a pool size of 25, a 60-90% reduction in cost per animal could be achieved by using real-time RT-PCR and ACE, compared with individual sample testing by IHC, ACE, or real-time RT-PCR. Because the true prevalence for a given herd is unknown until it is tested, the actual cost per animal and cost reduction may deviate slightly from the calculated dollar amount, depending on the prevalence, the herd size, and the number of animals to be tested. 19, 20 By using the combined real-time RT-PCR and ACE procedure, more than 27,000 samples were tested in a 3-year period. Analysis of the data showed that BVDV prevalence in Mississippi was relatively low, ranging from 0.24% to 0.72%. Although the presence of both BVDV-1 and BVDV-2 in 3 specimens was confirmed by repeated real-time RT-PCR testing, it is unusual to have a dual persistent infection with both genotypes. One possible explanation for this phenomenon is that these PI animals were exposed to a second BVDV virus of a different genotype. Analysis of the 59-UTR of 22 isolates revealed the predominance of BVDV-1b followed by BVDV-2a and the absence of BVDV-1a, which differed from the previously reported prevalent types in the central south United States (BVDV-1b only) or in the southwest United States (BVDV-1b followed by BVDV-1a and BVDV-2a). 6, 7, 29 Although genetic variations were detected within each subgenotype, 1b or 2a, it was unknown whether these variations were associated with any antigenic changes. Further study in this area will provide useful information for formulating successful vaccination programs.
